Patents by Inventor Michael Tal
Michael Tal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200147350Abstract: An access device places a medical article within a body space of a patient. The device has a needle that includes an elongated body and a needle hub. The device further includes a dilator disposed on and slideable along the elongated body of the needle and a medical article. The medical article is disposed on and slideable along the dilator. A track extends in a proximal direction from the dilator. The needle hub slides along at least a portion of the track between a first position and a second position. The device further includes a locking mechanism operably disposed between the track and the needle hub so as to inhibit further axial movement of the needle in the proximal direction when the needle hub is in the second position.Type: ApplicationFiled: January 9, 2020Publication date: May 14, 2020Inventors: Michael Tal, Janelle Anderson, Benjamin K. Yaffe, William J. McCreight, Robert Rabiner
-
Patent number: 10579535Abstract: A processor includes a processor core and a micro-op cache communicably coupled to the processor core. The micro-op cache includes a micro-op tag array, wherein tag array entries in the micro-op tag array are indexed according to set and way of set-associative cache, and a micro-op data array to store multiple micro-ops. The data array entries in the micro-op data array are indexed according to bank number of a plurality of cache banks and to a set within one cache bank of the plurality of cache banks.Type: GrantFiled: December 15, 2017Date of Patent: March 3, 2020Assignee: Intel CorporationInventors: Lihu Rappoport, Jared Warner Stark, IV, Franck Sala, Michael Tal, Gil Shmueli, Adrian Flesler
-
Publication number: 20190388266Abstract: An intrauterine contraceptive system may include a contraceptive intrauterine device, a retrieval thread permanently attached to the intrauterine device and an insertion device for inserting the intrauterine device into a uterus. The system may also include a release thread releasably coupled with the intrauterine device. The intrauterine device may be deployable out of a distal end of the insertion device and may be configured to change from a delivery configuration when housed in the insertion device to a deployed configuration when deployed in a uterus. The retrieval thread and the optional release thread may be at least partially housed within the insertion device during insertion of the intrauterine device into the uterus. The release thread may extend from the intrauterine device through the insertion device to an attachment point at or near a proximal end of the insertion device.Type: ApplicationFiled: August 27, 2019Publication date: December 26, 2019Inventors: Michael TAL, Bob H. KATZ, Mark James DeBISSCHOP
-
Patent number: 10398588Abstract: An intrauterine contraceptive system may include a contraceptive intrauterine device, a retrieval thread permanently attached to the intrauterine device and an insertion device for inserting the intrauterine device into a uterus. The system may also include a release thread releasably coupled with the intrauterine device. The intrauterine device may be deployable out of a distal end of the insertion device and may be configured to change from a delivery configuration when housed in the insertion device to a deployed configuration when deployed in a uterus. The retrieval thread and the optional release thread may be at least partially housed within the insertion device during insertion of the intrauterine device into the uterus. The release thread may extend from the intrauterine device through the insertion device to an attachment point at or near a proximal end of the insertion device.Type: GrantFiled: April 3, 2017Date of Patent: September 3, 2019Assignee: SEBELA VLC LIMITEDInventors: Michael Tal, Bob H. Katz, Mark James DeBisschop
-
Publication number: 20190213131Abstract: Systems and methods for stream cache memory retrieval include applying a stream cache to predict a sequence of instructions and data across multiple branches. Similar to a conventional computing cache, the stream cache stores and provides data or instructions more quickly than provided by slower data storage media, such as an instruction cache. The stream cache described herein provides the ability to predict instructions and data requests across multiple branches per cycle, and in particular across multiple taken branches per cycle. This stream cache increases instruction supply bandwidth while reducing overall power consumption by saving cycles of the branch predictor structures.Type: ApplicationFiled: January 11, 2018Publication date: July 11, 2019Inventors: Ariel Sabba, Shani Rehana, Michael Tal, Suzan Baransi, Lihu Rappoport, Jared Warner Stark, Franck Sala
-
Publication number: 20190188142Abstract: A processor includes a processor core and a micro-op cache communicably coupled to the processor core. The micro-op cache includes a micro-op tag array, wherein tag array entries in the micro-op tag array are indexed according to set and way of set-associative cache, and a micro-op data array to store multiple micro-ops. The data array entries in the micro-op data array are indexed according to bank number of a plurality of cache banks and to a set within one cache bank of the plurality of cache banks.Type: ApplicationFiled: December 15, 2017Publication date: June 20, 2019Inventors: Lihu RAPPOPORT, Jared Warner Stark iv, Franck Sala, Michael Tal, Gil Shmueli, Adrian Flesler
-
Publication number: 20190125576Abstract: A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device.Type: ApplicationFiled: December 18, 2018Publication date: May 2, 2019Inventors: Michael TAL, Bob KATZ, Mark James DEBISSCHOP, Peter WILSON, Oleg SHIKHMAN
-
Patent number: 10188546Abstract: An intrauterine contraceptive device may include a frame made completely or partially of a first metal having a first galvanic potential and at least one metallic member coupled with the frame that is made of a second metal having a second galvanic potential different from the first galvanic potential. In some embodiments, the first galvanic potential may be more anodic than the second galvanic potential. In alternative embodiments, the first galvanic potential may be more cathodic than the second galvanic potential. In one embodiment, the first metal is Nitinol, and the second metal is copper. In some embodiments, the first and second galvanic potentials may be configured to achieve, at least approximately, a desired copper ion elution rate for the intrauterine device.Type: GrantFiled: May 28, 2014Date of Patent: January 29, 2019Assignee: SEBELA VLC LIMITEDInventors: Michael Tal, Bob H. Katz, Scott M. Russell
-
Patent number: 10166141Abstract: A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device.Type: GrantFiled: August 5, 2015Date of Patent: January 1, 2019Assignee: SEBELA VLC LIMITEDInventors: Michael Tal, Bob H. Katz, Mark James DeBisschop, Peter Wilson, Oleg Shikhman
-
Patent number: 10159596Abstract: A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device.Type: GrantFiled: July 22, 2016Date of Patent: December 25, 2018Assignee: SEBELA VLC LIMITEDInventors: Michael Tal, Bob Katz, Mark James DeBisschop, Peter Wilson, Oleg Shikhman
-
Publication number: 20180244778Abstract: Humanized monoclonal antibodies (mAbs) or fragments thereof, to human Cluster of Differentiation 3 (CD3), which confer improved immune stimulation and stability, are disclosed. Pharmaceutical compositions comprising said mAbs and methods of treatment and optionally also prevention of diseases and disorders, such as autoimmune disorders, infectious diseases, and transplant rejection, that are susceptible to amelioration by binding to CD3, are also disclosed.Type: ApplicationFiled: May 14, 2018Publication date: August 30, 2018Inventors: Ronald Ellis, Michael Tal, Sarit Samira, Nurit Rachamim, Timothy David Jones, Francis Joseph Carr, Shahar Dotan
-
Patent number: 10022264Abstract: An intrauterine contraceptive system may include a contraceptive intrauterine device, a retrieval thread permanently attached to the intrauterine device and an insertion device for inserting the intrauterine device into a uterus. The system may also include a release thread releasably coupled with the intrauterine device. The intrauterine device may be deployable out of a distal end of the insertion device and may be configured to change from a delivery configuration when housed in the insertion device to a deployed configuration when deployed in a uterus. The retrieval thread and the optional release thread may be at least partially housed within the insertion device during insertion of the intrauterine device into the uterus. The release thread may extend from the intrauterine device through the insertion device to an attachment point at or near a proximal end of the insertion device.Type: GrantFiled: November 9, 2015Date of Patent: July 17, 2018Assignee: CONTRAMED, LLCInventors: Michael Tal, Bob H. Katz, Mark James DeBisschop
-
Patent number: 10000567Abstract: Humanized monoclonal antibodies (mAbs) or fragments thereof, to human Cluster of Differentiation 3 (CD3), which confer improved immune stimulation and stability, are disclosed. Pharmaceutical compositions comprising said mAbs and methods of treatment and optionally also prevention of diseases and disorders, such as autoimmune disorders, infectious diseases, and transplant rejection, that are susceptible to amelioration by binding to CD3, are also disclosed.Type: GrantFiled: March 12, 2013Date of Patent: June 19, 2018Assignee: Therapix Biosciences Ltd.Inventors: Ronald Ellis, Michael Tal, Sarit Samira, Nurit Rachamim, Timothy David Jones, Francis Joseph Carr, Shahar Dotan
-
Patent number: 9879076Abstract: Novel antibodies, methods and compositions for treatment of a disease which is susceptible to amelioration by the blocking of APP cleavage.Type: GrantFiled: March 13, 2014Date of Patent: January 30, 2018Assignee: RAMOT AT TEL AVIV UNIVERSITY LTD.Inventors: Sarit Samira, Nurit Rachamim, Michael Tal, Ronald Ellis, Idan Rakover, Rom E. Eliaz, Beka Solomon, Timothy David Jones, Francis Joseph Carr, Polina Rabinovich-Toidman, Meital Sooliman
-
Publication number: 20170202701Abstract: An intrauterine contraceptive system may include a contraceptive intrauterine device, a retrieval thread permanently attached to the intrauterine device and an insertion device for inserting the intrauterine device into a uterus. The system may also include a release thread releasably coupled with the intrauterine device. The intrauterine device may be deployable out of a distal end of the insertion device and may be configured to change from a delivery configuration when housed in the insertion device to a deployed configuration when deployed in a uterus. The retrieval thread and the optional release thread may be at least partially housed within the insertion device during insertion of the intrauterine device into the uterus. The release thread may extend from the intrauterine device through the insertion device to an attachment point at or near a proximal end of the insertion device.Type: ApplicationFiled: April 3, 2017Publication date: July 20, 2017Applicant: CONTRAMED, LLCInventors: Michael TAL, Bob H. KATZ, Mark James DeBISSCHOP
-
Publication number: 20170165103Abstract: A method of manufacturing an intrauterine device (IUD) for contraception that has a desired copper elution rate is described. The method may involve selecting an elongate shape memory member comprising a first metal having a first galvanic potential, selecting at least one attachment member comprising a second metal having a second galvanic potential that is different from the first galvanic potential, attaching the attachment member(s) to the shape memory member, and shaping the shape memory member to form a frame of the intrauterine contraceptive device. The first metal and the second metal are specifically selected as materials for the shape memory member and the attachment member(s), in order to achieve the desired copper elution rate.Type: ApplicationFiled: February 24, 2017Publication date: June 15, 2017Applicant: CONTRAMED, LLCInventors: Michael TAL, Bob H. KATZ, Scott M. RUSSELL
-
Patent number: 9610191Abstract: An intrauterine contraceptive system may include a contraceptive intrauterine device, a retrieval thread permanently attached to the intrauterine device and an insertion device for inserting the intrauterine device into a uterus. The system may also include a release thread releasably coupled with the intrauterine device. The intrauterine device may be deployable out of a distal end of the insertion device and may be configured to change from a delivery configuration when housed in the insertion device to a deployed configuration when deployed in a uterus. The retrieval thread and the optional release thread may be at least partially housed within the insertion device during insertion of the intrauterine device into the uterus. The release thread may extend from the intrauterine device through the insertion device to an attachment point at or near a proximal end of the insertion device.Type: GrantFiled: July 8, 2015Date of Patent: April 4, 2017Assignee: CONTRAMED, LLCInventors: Michael Tal, Bob H. Katz, Mark James DeBisschop
-
Publication number: 20170056237Abstract: A system for treating a fallopian tube to promote contraception includes a catheter device, a tissue disrupting head coupled with the catheter device, and a fluid delivery port for delivering a sclerosant to the mucosal lining of the fallopian tube before, during or after disruption of the mucosal lining by the tissue disrupting head. The catheter device may include a handle and a catheter shaft having a proximal end coupled with the handle and a distal end sized and configured to be advanced through a cervix and into the fallopian tube. The tissue disrupting head may include at least one tissue disrupting member configured to operable to mechanically disrupt a mucosal lining of the fallopian tube by contacting the tissue disrupting member with the mucosal lining and moving the tissue disrupting head. The fluid delivery port may be located in the catheter shaft or the tissue disrupting head.Type: ApplicationFiled: September 1, 2015Publication date: March 2, 2017Inventor: Michael Tal
-
Publication number: 20160331579Abstract: A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device.Type: ApplicationFiled: July 22, 2016Publication date: November 17, 2016Inventors: Michael Tal, Bob Katz, Mark James DeBisschop, Peter Wilson, Oleg Shikhman
-
Patent number: 9427351Abstract: A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device.Type: GrantFiled: July 10, 2015Date of Patent: August 30, 2016Assignee: CONTAMED, LLCInventors: Michael Tal, Bob H. Katz, Mark James DeBisschop, Peter Wilson, Oleg Shikhman